Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes.

Furthermore, highly significant differences were observed between the exclusionary FABP4 cut-off value (> 2.30) and thalassemia-associated cardiometabolic adverse events ( p -value ≤ 0.05, Table 7 ).

also in 132,142 other papers